Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – ...

senior vice president of clinical informatics solutions and health nexus. Also taking part in the webinar is Dr. Ben Freiberg, Principal Informatics Systems Lead with Genentech’s gCS ...